HIV-associated neurocognitive disorder in Australia: A case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

Journal of NeuroVirology

Volumn 20, Issue 3, 2014, Pages 258-268

  Cysique, Lucette A ^a,b,c   Heaton, Robert K ^d   Kamminga, Jody ^b,c   Lane, Tammy ^c   Gates, Thomas M ^a,c   Moore, Danielle M ^c   Hubner, Emma ^c   Carr, Andrew ^a,c   Brew, Bruce J ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV associated neurocognitive disorder; HIV AIDS; Neuropsychological functions; Normative data

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDEPENDENCE; MALE; MEDICAL RESEARCH; MEN WHO HAVE SEX WITH MEN; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SELF CONCEPT; SELF REPORT; UNITED STATES; AGING; AIDS DEMENTIA COMPLEX; CLASSIFICATION; COGNITION DISORDERS; HEALTH; HOMOSEXUALITY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VIROLOGY;

AGING; AIDS DEMENTIA COMPLEX; AUSTRALIA; COGNITION DISORDERS; GLOBAL HEALTH; HOMOSEXUALITY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84905374338     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0242-x     Document Type: Article

References (38)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799 (Pubitemid 350059308)
2. Australian Neuroscience Society (2010) Australian health & medical research funding summary. http://www.ans.org.au/uploads/documents/ANSweb- A&NZResearch%20funding.pdf
3. Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK (2012) Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol 26:894-908
4. Brandt J, Benedict RH (2001) Hopkins verbal learning test-revised. Professional manual. Psychological Assessment Resources, Inc., Lutz
5. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319 (Pubitemid 39277061)
6. Cohen J, Cohen P (1983)Applied multiple regression/correlation analysis for the behavioral sciences. Erlbaum: Hillsdale, NJ
7. Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller EN (2007) Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 69:2213-2220 (Pubitemid 350294676)
8. Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17:176-83
9. Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C (2013) HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One 8:e61738
10. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743-753 (Pubitemid 351640675)
11. Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17:491-501
12. Garvey L, Surendrakumar V, Winston A (2011) Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials 12:333-338
13. Green A, Garrick T, Sheedy D, Blake H, Shores A, Harper C (2008) Repeatable battery for the assessment of neuropsychological status (RBANS): preliminary Australian normative data. Aust J Psychol 60:72-79
14. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004a) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331 (Pubitemid 38779804)
15. Heaton RK, Miller SW, Taylor MJ, Grant I (2004b) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults Scoring Program. Psychological Assessment Resources, Odessa
16. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
17. Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, Pardo CA, Paul RH, Pulliam L, Robertson K, Royal W 3rd, Sacktor N, Sithinamsuwan P, Smith DM, Valcour V, Wigdahl B, Wood C (2013) Global NeuroAIDS roundtable. J Neurovirol 19:1-9
18. Kamminga J, Cysique LA, Lu G, Batchelor J, Brew BJ (2013) Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep 10:342-55
19. Lane TA, Moore DM, Batchelor J, Brew BJ, Cysique LA (2012) Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status. Neuropsychology 26:713-722
20. Law MG, Woolley I, Templeton DJ, Roth N, Chuah J, Mulhall B, Canavan P, McManus H, Cooper DA, Petoumenos K (2011) Trends in detectable viral load by calendar year in the Australian HIVobservational database. J Int AIDS Soc 14:10
21. Letendre S (2011) Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 19:137-142
22. Lipsey M, Wilson D (2001) Practical meta-analysis. Sage Publications, London
23. Manly JJ, Byrd DA, Touradji P, Stern Y (2004) Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol 11:37-46 (Pubitemid 39295187)
24. Mitrushina M, Boone KB, Razani J, D'Elia LF (2005) Handbook of normative data for neuropsychological assessment, 2nd edn. Oxford University Press, Oxford
25. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, Garolera M, Perez-Alvarez N, Molto J, Gomez G, Clotet B (2008) Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retrovir 24:1301-1307
26. Nelson H, Willison J (1991). National Adult Reading Test (NART). Test manual, 2nd edn. NFER-NELSON: Windsor, UK
27. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142 (Pubitemid 34520894)
28. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite longstanding suppression of viremia. AIDS 24:1243-1250
29. Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, Oxford
30. Sullivan R, Senior G, Henessy M (2000) Regression equations: Australian age-education and premorbid cognitive/intellectual estimates for the WAIS-III In: Assessment Psychology Online: http://www.assessmentpsychology.com/iq- estimates-3.htm
31. Taylor MJ, Heaton RK (2001) Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 7:867-874 (Pubitemid 34026550)
32. The Kirby Institute (2012) HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2012. In: Institute TK (ed) The University of New South Wales, Sydney, NSW 2052
33. The Kirby Institute (2013) HIV, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2013. In: Institute TK (ed) The University of New South Wales, Sydney, NSW 2052
34. UNAIDS (2012) UNAIDS Report on the global AIDS epidemic 2012. WHO: (Digital version)
35. Williams JM, Cottle CC (2011)Acorrection for recruitment bias in norms derived from meta-analysis. Psychol Assess 23:856-864
36. Winston A, Arenas-Pinto A, Stohr W, Fisher M, Orkin CM, Aderogba K, De Burgh-Thomas A, O'Farrell N, Lacey CJ, Leen C, Dunn D, Paton NI (2013) Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One 8:e61949
37. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152-168
38. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75: 864-73